Laverock Therapeutics
Curated by SignalDeveloper of next generation of programmable cell therapies
Overview
Developer of next generation of programmable cell therapies. The company utilizes gene editing induced gene silencing (GEiGS) technology, and its associated computational platform, to engineer induced pluripotent stem cell (iPSC) derived cell therapies.
Key facts
- Founded
- 2021
- Headquarters
- Stevenage, United Kingdom
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- Commercial model
- Sign up to view
Contact
- Sign up to view